What are the recommended cloxacillin dosing guidelines for children, including intravenous, intramuscular, and oral routes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cloxacillin Pediatric Dosing

For methicillin-susceptible staphylococcal infections in children, cloxacillin should be dosed at 50 mg/kg every 6 hours (QDS) intravenously, with a maximum of 200 mg/kg/day, or 50 mg/kg every 6 hours orally for step-down therapy.

Intravenous Dosing

Standard Dosing for Most Infections

  • 50 mg/kg every 6 hours (QDS) for children >3 years old 1
  • Maximum daily dose: 200 mg/kg/day divided into 4 doses

Specific Clinical Contexts

For Staphylococcal Pneumonia:

  • Parenteral: 150-200 mg/kg/day divided every 6-8 hours (equivalent to oxacillin dosing) 2, 3
  • This higher dosing is preferred for serious methicillin-susceptible S. aureus (MSSA) infections

For Osteomyelitis:

  • 50 mg/kg QDS intravenously for 10 days, then switch to oral therapy 1
  • Total treatment duration: 3 weeks

For Mastoiditis:

  • 50 mg/kg QDS for 10 days 1

Oral Dosing (Step-Down Therapy)

  • 50 mg/kg every 6 hours for continuation therapy after initial IV treatment 1
  • Used after clinical improvement on parenteral therapy
  • Particularly relevant for osteomyelitis (switch after 10 days IV to complete 3 weeks total)

Important Clinical Considerations

Age-Specific Guidance

The evidence primarily supports cloxacillin use in children >3 years old 1. For younger children and neonates, alternative anti-staphylococcal agents (nafcillin, oxacillin, or cefazolin) have more established dosing guidelines 4.

Route Selection Algorithm

  1. Use IV cloxacillin for:

    • Severe infections (pneumonia, osteomyelitis, mastoiditis)
    • Hospitalized patients
    • Initial empiric therapy for suspected MSSA
  2. Switch to oral cloxacillin when:

    • Clinical improvement documented
    • Afebrile for 24-48 hours
    • Tolerating oral intake
    • Typically after 7-10 days IV for most infections

Common Pitfalls to Avoid

Underdosing in serious infections: The WHO guideline recommends 50 mg/kg QDS 1, but for severe staphylococcal pneumonia, the higher range of 150-200 mg/kg/day (equivalent to oxacillin) is more appropriate 2, 3. Don't use the lower dose for life-threatening infections.

Renal function considerations: While specific pediatric renal dosing adjustments for cloxacillin are not well-established in the guidelines, patients with preserved renal function (eGFR >90) may require higher doses to maintain therapeutic levels, as demonstrated in adult studies 5. Monitor clinical response closely.

Geographic resistance patterns: Cloxacillin is only appropriate for methicillin-susceptible staphylococci. In regions with high MRSA prevalence, empiric vancomycin or clindamycin should be used instead 2, 3.

Practical Implementation

For empiric therapy pending cultures:

  • In settings where S. aureus is the dominant pathogen (e.g., India), combine cloxacillin with ceftriaxone to cover both staphylococci and streptococci 6
  • This combination is particularly relevant for empyema and complicated pneumonia

Maximum doses:

  • Do not exceed adult equivalent doses
  • For a 50 kg child, maximum would be approximately 2 g every 6 hours

Evidence Quality Note

The cloxacillin dosing recommendations come primarily from WHO guidelines 1 and are extrapolated from oxacillin/flucloxacillin dosing in major infectious disease society guidelines 2, 3. Direct pediatric pharmacokinetic studies for cloxacillin are limited, with significant inter-center variability noted in practice 7. The dosing recommendations represent consensus expert opinion based on clinical experience with isoxazolyl penicillins as a class.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.